Sanofi/$SNY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sanofi
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Ticker
$SNY
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
82,878
ISIN
US80105N1054
Website
Sanofi Metrics
BasicAdvanced
$121B
8.63
$5.72
0.48
$1.48
3.26%
Price and volume
Market cap
$121B
Beta
0.48
52-week high
$60.12
52-week low
$45.80
Average daily volume
2.6M
Dividend rate
$1.48
Financial strength
Total debt to equity
23.008
Interest coverage (TTM)
17.14%
Management effectiveness
Valuation
Price to earnings (TTM)
8.625
Price to revenue (TTM)
1.202
Price to book
1.42
Price to tangible book (TTM)
5.52
Dividend yield (TTM)
2.99%
Forward dividend yield
3.26%
Growth
Revenue change (TTM)
-2.42%
Earnings per share change (TTM)
39.56%
3-year revenue growth (CAGR)
3.84%
3-year earnings per share growth (CAGR)
-1.65%
What the Analysts think about Sanofi
Analyst ratings (Buy, Hold, Sell) for Sanofi stock.
Sanofi Financial Performance
Revenues and expenses
Sanofi Earnings Performance
Company profitability
Sanofi News
AllArticlesVideos
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
Business Wire·12 hours ago
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
GlobeNewsWire·23 hours ago
Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz
CNBC Television·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jun12
Sanofi
Dividend·Payment
$2.212154Per share
FAQs
What’s the current market cap for Sanofi stock?
Sanofi (SNY) has a market cap of $121B as of June 04, 2025.
What is the P/E ratio for Sanofi stock?
The price to earnings (P/E) ratio for Sanofi (SNY) stock is 8.63 as of June 04, 2025.
Does Sanofi stock pay dividends?
Yes, the Sanofi (SNY) stock pays dividends to shareholders. As of June 04, 2025, the dividend rate is $1.47849 and the yield is 3.26%. Sanofi has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Sanofi dividend payment date?
The next Sanofi (SNY) dividend payment is scheduled for June 12, 2025.
What is the beta indicator for Sanofi?
Sanofi (SNY) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.